ArticleLeukemia2005

Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.

C G Cerveny et al.PubMed ↗Publisher ↗

No numbers read from the abstract.